Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanne Prytz

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Lakartidningen|July 28, 2009
[Iliopsoas abscess--difficult to suspect, easy to diagnose]David Blomstrand, Hanne Prytz
Lakartidningen|December 25, 2012
[Rare metabolic diseases can be manifested as liver disease]Hanne Prytz, Stefan Lindgren
Lakartidningen|July 22, 2010
[Difficult to stop primary sclerosing cholangitis]Annika Bergquist, Hanne Prytz, Einar Björnsson
Scandinavian Journal of Gastroenterology|February 21, 2015
Predictors of mortality among patients with compensated and decompensated liver cirrhosis: the role of bacterial infections and infection-related acute-on-chronic liver failureKonstantina Sargenti, Hanne Prytz, Emma Nilsson, et al.
Scandinavian Journal of Gastroenterology|August 8, 2019
Risk and outcome of hepatocellular carcinoma in liver cirrhosis in Southern Sweden: a population-based studyEmma Nilsson, Harald Anderson, Konstantina Sargenti, et al.
Scandinavian Journal of Gastroenterology|March 8, 2018
Patients with liver cirrhosis show worse survival if decompensation occurs later during course of disease than at diagnosisEmma Nilsson, Harald Anderson, Konstantina Sargenti, et al.
European Journal of Gastroenterology & Hepatology|May 27, 2015
Bacterial infections in alcoholic and nonalcoholic liver cirrhosisKonstantina Sargenti, Hanne Prytz, Emma Nilsson, et al.
Alimentary Pharmacology & Therapeutics|April 9, 2019
Clinical course and mortality by etiology of liver cirrhosis in Sweden: a population based, long-term follow-up study of 1317 patientsEmma Nilsson, Harald Anderson, Konstantina Sargenti, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 22, 2014
Healthcare-associated and nosocomial bacterial infections in cirrhosis: predictors and impact on outcomeKonstantina Sargenti, Hanne Prytz, Anna Strand, et al.
Hepatology (Baltimore, Md.)|November 30, 2006
Dynamic FDG-PET is useful for detection of cholangiocarcinoma in patients with PSC listed for liver transplantationHanne Prytz, Susanne Keiding, Einar Björnsson, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Lakartidningen|July 28, 2009
[Iliopsoas abscess--difficult to suspect, easy to diagnose]David Blomstrand, Hanne Prytz
Lakartidningen|December 25, 2012
[Rare metabolic diseases can be manifested as liver disease]Hanne Prytz, Stefan Lindgren
Lakartidningen|July 22, 2010
[Difficult to stop primary sclerosing cholangitis]Annika Bergquist, Hanne Prytz, Einar Björnsson
Scandinavian Journal of Gastroenterology|February 21, 2015
Predictors of mortality among patients with compensated and decompensated liver cirrhosis: the role of bacterial infections and infection-related acute-on-chronic liver failureKonstantina Sargenti, Hanne Prytz, Emma Nilsson, et al.
Scandinavian Journal of Gastroenterology|August 8, 2019
Risk and outcome of hepatocellular carcinoma in liver cirrhosis in Southern Sweden: a population-based studyEmma Nilsson, Harald Anderson, Konstantina Sargenti, et al.
Scandinavian Journal of Gastroenterology|March 8, 2018
Patients with liver cirrhosis show worse survival if decompensation occurs later during course of disease than at diagnosisEmma Nilsson, Harald Anderson, Konstantina Sargenti, et al.
European Journal of Gastroenterology & Hepatology|May 27, 2015
Bacterial infections in alcoholic and nonalcoholic liver cirrhosisKonstantina Sargenti, Hanne Prytz, Emma Nilsson, et al.
Alimentary Pharmacology & Therapeutics|April 9, 2019
Clinical course and mortality by etiology of liver cirrhosis in Sweden: a population based, long-term follow-up study of 1317 patientsEmma Nilsson, Harald Anderson, Konstantina Sargenti, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 22, 2014
Healthcare-associated and nosocomial bacterial infections in cirrhosis: predictors and impact on outcomeKonstantina Sargenti, Hanne Prytz, Anna Strand, et al.
Hepatology (Baltimore, Md.)|November 30, 2006
Dynamic FDG-PET is useful for detection of cholangiocarcinoma in patients with PSC listed for liver transplantationHanne Prytz, Susanne Keiding, Einar Björnsson, et al.
Pageof 3